Rasagiline Tablets
Pre-Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- SPE2D2-25-R-0020
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for a national requirements contract for Rasagiline Tablets, specifically 0.5 MG and 1 MG tablets in 30 count bottles. This procurement will serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. The acquisition will be unrestricted and fully competitive, structured as a firm-fixed price requirements contract with a one-year base period and four one-year options. The solicitation will be conducted under FAR Part 12 as a commercial item procurement, and all sources may submit proposals for agency consideration. The projected solicitation date is August 2025, with interested parties advised to contact Kyle Lewicki at (445) 737-0977 or kyle.lewicki@dla.mil for questions and to set up automated notifications for any changes.
This procurement does not utilize any set-aside designations, making it available to all qualified contractors regardless of socioeconomic status. No incumbent contractors or current service providers are mentioned in the notice. While specific award values or budget ranges are not disclosed, the notice indicates that annual usage estimates will be provided in the Schedule of Supplies section of the forthcoming solicitation. The contract structure spans a potential five-year period with the base year plus four option years, establishing a national supply source for these pharmaceutical products. The solicitation will be posted on both the DLA Bid Board System (DIBBS) and Sam.Gov when released, with DLA reserving the right to issue the solicitation before or after the projected August 2025 timeframe.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rasagiline Tablets. Procurement details follow.
Rasagiline 0.5 MG Tablet and Rasagiline 1 MG Tablet in 30 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Kyle Lewicki at (445) 737-0977, (kyle.lewicki@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is August of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Rasagiline Tablets | Award Notice | |
| Pharm Manuf/Distr Div - FSA | Award Notice | |
| Rasagiline Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity